191 related articles for article (PubMed ID: 18691108)
1. Chronic graft-versus-host disease.
Bolaños-Meade J; Vogelsang GB
Curr Pharm Des; 2008; 14(20):1974-86. PubMed ID: 18691108
[TBL] [Abstract][Full Text] [Related]
2. Novel strategies for steroid-refractory acute graft-versus-host disease.
Bolaños-Meade J; Vogelsang GB
Curr Opin Hematol; 2005 Jan; 12(1):40-4. PubMed ID: 15604890
[TBL] [Abstract][Full Text] [Related]
3. Chronic graft versus host disease.
Baird K; Pavletic SZ
Curr Opin Hematol; 2006 Nov; 13(6):426-35. PubMed ID: 17053454
[TBL] [Abstract][Full Text] [Related]
4. Chronic graft-versus-host disease.
Cutler C; Antin JH
Curr Opin Oncol; 2006 Mar; 18(2):126-31. PubMed ID: 16462180
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
[TBL] [Abstract][Full Text] [Related]
6. ATP downregulation in mononuclear cells from children with graft-versus-host disease following extracorporeal photochemotherapy.
Perutelli P; Rivabella L; Lanino E; Pistoia V; Dini G
Haematologica; 2002 Mar; 87(3):335-6. PubMed ID: 11869954
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
8. [Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation].
Bykova TA; Kozlov AV; Stancheva NV; Semënova EV; Kulagina II; Bondarenko SN; Vavilov VN; Morozova EV; Zubarovskaia LS; Afanas'ev BV
Ter Arkh; 2013; 85(8):60-8. PubMed ID: 24137966
[TBL] [Abstract][Full Text] [Related]
9. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
Lee SJ; Wolff D; Kitko C; Koreth J; Inamoto Y; Jagasia M; Pidala J; Olivieri A; Martin PJ; Przepiorka D; Pusic I; Dignan F; Mitchell SA; Lawitschka A; Jacobsohn D; Hall AM; Flowers ME; Schultz KR; Vogelsang G; Pavletic S
Biol Blood Marrow Transplant; 2015 Jun; 21(6):984-99. PubMed ID: 25796139
[TBL] [Abstract][Full Text] [Related]
10. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.
Carpenter PA; Kitko CL; Elad S; Flowers ME; Gea-Banacloche JC; Halter JP; Hoodin F; Johnston L; Lawitschka A; McDonald GB; Opipari AW; Savani BN; Schultz KR; Smith SR; Syrjala KL; Treister N; Vogelsang GB; Williams KM; Pavletic SZ; Martin PJ; Lee SJ; Couriel DR
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1167-87. PubMed ID: 25838185
[TBL] [Abstract][Full Text] [Related]
11. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Urban CH; Deutschmann A; Kerbl R; Lackner H; Schwinger W; Königsrainer A; Margreiter R
Bone Marrow Transplant; 2002 Oct; 30(8):535-7. PubMed ID: 12379895
[TBL] [Abstract][Full Text] [Related]
12. Chronic graft-versus-host disease following allogeneic peripheral blood and bone marrow stem cell transplants: a single center experience.
Takami A; Ishiyama K; Asakura H; Shiobara S; Nakao S
Haematologica; 2002 Jun; 87(6):664-6. PubMed ID: 12031928
[No Abstract] [Full Text] [Related]
13. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.
Pavletic SZ; Lee SJ; Socie G; Vogelsang G
Bone Marrow Transplant; 2006 Nov; 38(10):645-51. PubMed ID: 16980994
[TBL] [Abstract][Full Text] [Related]
14. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
16. [2018 update on chronic graft-versus-host disease].
Inamoto Y
Rinsho Ketsueki; 2018; 59(10):2300-2306. PubMed ID: 30305539
[TBL] [Abstract][Full Text] [Related]
17. Ocular graft-versus-host disease: a review.
Shikari H; Antin JH; Dana R
Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
[TBL] [Abstract][Full Text] [Related]
18. 2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.
Pavletic SZ; Vogelsang GB; Lee SJ
Biol Blood Marrow Transplant; 2015 Mar; 21(3):387-8. PubMed ID: 25572033
[No Abstract] [Full Text] [Related]
19. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
20. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.
Hebart H; Ehninger G; Schmidt H; Berner B; Reuss-Borst M; Waller HD; Müller CA; Einsele H
Bone Marrow Transplant; 1995 Jun; 15(6):891-4. PubMed ID: 7581087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
